Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NNC0114-0006 in Active Crohn's Disease
NCT01751152Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Feb 2013
- Primary completion
- Dec 2014
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of NNC0114-0000-0005 in Crohn's disease, sponsored by Novo Nordisk. Started Feb 2013; status: completed.
02
Drugs
NNC0114-0000-0005
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01751152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01751152.